- Home
- FLC vs SENS Comparison
FLC vs SENS Comparison
Compare FLC & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FLC | SENS |
|---|---|---|
| Founded | N/A | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 184.0M | 308.5M |
| IPO Year | 2003 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FLC | SENS |
|---|---|---|
| Price | $16.74 | $6.83 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $22.70 |
| AVG Volume (30 Days) | 22.6K | ★ 451.5K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $16,389,000.00 |
| Revenue This Year | N/A | $70.20 |
| Revenue Next Year | N/A | $59.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.85 |
| 52 Week Low | $14.80 | $0.41 |
| 52 Week High | $18.09 | $8.75 |
Technical Indicators
Market Signals| Indicator | FLC | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 41.18 | 52.61 |
| Support Level | N/A | $6.62 |
| Resistance Level | $17.68 | $6.87 |
| Average True Range (ATR) | 0.22 | 0.42 |
| MACD | 0.01 | 0.08 |
| Stochastic Oscillator | 41.33 | 86.80 |
Price Performance
Historical ComparisonAbout FLC Flaherty & Crumrine Total Return Fund Inc
Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.